黑人成人阿尔茨海默氏症耻辱感调查研究:黑人身份与生物标记诊断的交叉性。

IF 2.6 3区 医学 Q1 ETHNIC STUDIES Ethnicity & Health Pub Date : 2024-11-01 Epub Date: 2024-07-30 DOI:10.1080/13557858.2024.2385110
Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger
{"title":"黑人成人阿尔茨海默氏症耻辱感调查研究:黑人身份与生物标记诊断的交叉性。","authors":"Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger","doi":"10.1080/13557858.2024.2385110","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.</p><p><strong>Design: </strong>We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified <i>Family Stigma in Alzheimer's Disease Scale</i> (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.</p><p><strong>Results: </strong>Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: <i>structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity,</i> and <i>social distance</i>. In the biomarker positive condition, worries about <i>structural discrimination</i> were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for <i>negative symptom attributions</i> (DOR, 0.51 [95%CI, 0.28-0.90]).</p><p><strong>Conclusion: </strong>While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.</p>","PeriodicalId":51038,"journal":{"name":"Ethnicity & Health","volume":" ","pages":"946-962"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560502/pdf/","citationCount":"0","resultStr":"{\"title\":\"A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.\",\"authors\":\"Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger\",\"doi\":\"10.1080/13557858.2024.2385110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.</p><p><strong>Design: </strong>We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified <i>Family Stigma in Alzheimer's Disease Scale</i> (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.</p><p><strong>Results: </strong>Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: <i>structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity,</i> and <i>social distance</i>. In the biomarker positive condition, worries about <i>structural discrimination</i> were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for <i>negative symptom attributions</i> (DOR, 0.51 [95%CI, 0.28-0.90]).</p><p><strong>Conclusion: </strong>While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.</p>\",\"PeriodicalId\":51038,\"journal\":{\"name\":\"Ethnicity & Health\",\"volume\":\" \",\"pages\":\"946-962\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560502/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ethnicity & Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13557858.2024.2385110\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ETHNIC STUDIES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethnicity & Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13557858.2024.2385110","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ETHNIC STUDIES","Score":null,"Total":0}
引用次数: 0

摘要

目的:我们迫切需要了解黑人成年人对阿尔茨海默病(AD)的成见。黑人社区承受着过重的阿尔茨海默病负担,而最近在使用阿尔茨海默病生物标志物进行早期诊断方面取得的进展可能会影响与阿尔茨海默病相关的耻辱感。我们的研究目标是描述自我认同的黑人参与者群体中的注意力缺失症耻辱感特征,并测试注意力缺失症生物标志物检测结果会如何影响这种耻辱感:设计:我们对 1150 名自我认同的黑人成年人进行了抽样调查,他们被随机分配阅读一个虚构人物的小故事,该人物被描述为生物标志物检测结果呈阳性或阴性。读完小故事后,参与者填写了修改后的阿尔茨海默病家庭耻辱感量表(FS-ADS)。我们比较了按年龄、性别和美国人口普查地区划分的不同组别之间的 FS-ADS 分数。我们研究了这些分组与阿兹海默症生物标志物测试结果之间的相互作用:结果:与 65 岁以下的参与者相比,65 岁以上的参与者在所有 7 个 FS-ADS 领域的得分都较低(污名化程度较低):结构性歧视、消极严重性归因、消极审美归因、反感、支持、怜悯和社会距离。在生物标志物阳性的情况下,对结构性歧视的担忧大于生物标志物阴性的情况,而且在统计学上两个年龄组的担忧相似(DOR,0.39 [95%CI,0.22-0.69])。这一结果模式与消极症状归因相似(DOR,0.51 [95%CI,0.28-0.90]):结论:虽然老年人对注意力缺失症的污名化程度低于年轻人,但注意力缺失症生物标志物检测同样会引起对结构性歧视和消极严重性归因的高度关注。因此,使用注意力缺失症生物标志物诊断可能会增加注意力缺失症的耻辱感,并加剧已知会影响一些黑人成年人注意力缺失症诊断的医疗差距。注意力缺失症诊断的进步可能会与社会和结构因素相互作用,从而对黑人成年人群体产生不同的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.

Objective: We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.

Design: We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified Family Stigma in Alzheimer's Disease Scale (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.

Results: Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity, and social distance. In the biomarker positive condition, worries about structural discrimination were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for negative symptom attributions (DOR, 0.51 [95%CI, 0.28-0.90]).

Conclusion: While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ethnicity & Health
Ethnicity & Health 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.50
自引率
0.00%
发文量
42
审稿时长
>12 weeks
期刊介绍: Ethnicity & Health is an international academic journal designed to meet the world-wide interest in the health of ethnic groups. It embraces original papers from the full range of disciplines concerned with investigating the relationship between ’ethnicity’ and ’health’ (including medicine and nursing, public health, epidemiology, social sciences, population sciences, and statistics). The journal also covers issues of culture, religion, gender, class, migration, lifestyle and racism, in so far as they relate to health and its anthropological and social aspects.
期刊最新文献
'COVID impacted my life in so many ways': a qualitative study of the lived experiences of the COVID-19 pandemic among people of Black ethnicities living with HIV in England. A paradox of white privilege: race, psychological resilience, and mental well-being during a public health crisis. 'I didn't expect to be so close to being diabetic': beliefs of prediabetes and diabetes prevention among Hispanic men at a federally qualified health center. Psychological distress in Asian American informal caregivers: an analysis by disaggregated ethnic groups. Racial diversity, interracial trust, and mental distress in post-apartheid South Africa.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1